[1]叶常青,刘长安,朱茂祥.《放射性肿瘤病因判断标准》解读[J].国际放射医学核医学杂志,2012,36(4):210-213.[doi:10.3760/cma.j.issn.1673-4114.2012.04.004]
　YE Chang-qing,LIU Chang-an,ZHU Mao-xiang.Explanation of Judgment Criteria for Cause of Radiogenic Neoplasms[J].International Journal of Radiation Medicine and Nuclear Medicine,2012,36(4):210-213.[doi:10.3760/cma.j.issn.1673-4114.2012.04.004]
点击复制

《放射性肿瘤病因判断标准》解读(/HTML)
分享到：

《国际放射医学核医学杂志》[ISSN:1673-4114/CN:12-1381/R]

卷:
36
期数:
2012年第4期
页码:
210-213
栏目:
标准解读
出版日期:
1900-01-01

文章信息/Info

Title:
Explanation of Judgment Criteria for Cause of Radiogenic Neoplasms
作者:
叶常青1;  刘长安2;  朱茂祥1
1. 军事医学科学院放射与辐射医学研究所放射毒理与辐射危害评价研究室, 北京 100850;
2. 中国疾病预防控制中心辐射防护与核安全医学所政策标准研究室, 北京 100088
Author(s):
YE Chang-qing1;  LIU Chang-an2;  ZHU Mao-xiang1
Department of Radiotoxicology and Assessment for Radiation Detriment, Institute of Radiation Medicine, Academy of Military Medical Sciences, Beijing 100850, China
关键词:
肿瘤; 辐射损伤; 职业卫生标准
Keywords:
Neoplasms; Radiation injuries; Occupational health criteria
DOI:
10.3760/cma.j.issn.1673-4114.2012.04.004
摘要:
《放射性肿瘤病因判断标准》是《放射性肿瘤诊断标准》的修订版本,主要修改点有两方面:在判断标准上,一是可用于估算病因概率(Pc)的癌症的数量由5种扩大到10种,二是已发生的癌症与辐射相关联的病因判断标准由原标准中的PC≥50%改为取95%可信限上限的PC≥50%;在估算方法上,除了基于超额相对危险外,还增加了基于超额绝对危险来估算PC。这些改进旨在在结合中国国情的基础上,符合国际发展趋势,尽可能保护索赔者的权益。
Abstract:
The revised version of Diagnosis Criteria for Radiogenic Neoplasms (2002) is Judgment Criteria for Cause of Radiogenic Neoplasms (2009). There were two main modifications in the new edition:judgment criteria and estimation method. In respect of the judgment criteria, one was that the kinds of neoplasms which can allowed to estimates the probability of causation (PC) enlarged from 5 to 10, the another was PC≥50% in the 0.95 profile quantiles was instead of PC≥50% in the 0.5 one as the judgment criteria. In respect of basic parameters, besides the excess relative risk, the excess absolute risk was added for estimation of PC. All of them were aimed to protect the fights and interest of the claimant according to the situation of China and correspond to the international development trend.

参考文献/References:

[1] National Institutes of Health. Report of the National Institutes of Health Ad Hoe Working Group to develop radioepidemiologieal tables. NIH Publication No.85-2748. Bethesda(MD):NIH, 1985.
[2] 国家技术监督局,中华人民共和国卫生部.GBl6386-1996放射性肿瘤判断标准及处理原则.北京:中国标准出版社,1996.
[3] 中华人民共和国职业病防治法.2001-10-27.
[4] 叶常青,龚诒芬,孙全富,等.放射性肿瘤的判断-科学基础和损害赔偿.北京:科学出版社,2007.
[5] International Atomic Energy Agency. Methods for estimating the probability of cancer from occupational radiation exposure. IAEATECDOC-870. Vienna:IAEA, 1996.
[6] International Atomic Energy Agency, International Labour Office. Action plan for occupational radiation protection. Vienna:IAEA, 2003.
[7] 中华人民共和国卫生部.GBZ97-2002放射性肿瘤诊断标准.北京:人民卫生出版社,2002.
[8] US Department of Health and Human Services, National Institutes of Health, National Cancer Institute. Report of the NCI-CDC working group to revise the 1985 NIH radioepidemiological tables. NIH Publication No.03-5387. Washingtom(DC):NIH, 2003.
[9] Intemational Commission Radiological Protection.国际放射防护委员会2007年建议书(国际放射防护委员会第103号出版物).潘自强,周永增,周平坤,等,译.北京:原子能出版社,2008.
[10] 刘长安.姜恩海.贾廷珍.对我国放射性疾病诊断标准现状的讨论.中国卫生监督杂志,2006,13(1):36-40.
[11] 马吉增,张良安,刘福东,等.职业照射,辟舀自强,刘森林,马吉噌,等.中国辐射水平.北京:原子能出版社,2010:170-238.
[12] 夏益华.辐射防护基本点的演变.辐射防护,2006,26(2):113-121.
[13] Intemational Commission Radiological Protection.国际放射防护委员会1990年建议书(国际放射防护委员会第60号出版物).李德平,孙世荃,陈明浚,等,译.北京:原子能出版社,1991.

相似文献/References:

[1]何燕,苏晋,郑晓霞,等.P-糖蛋白抑制剂在PET显像中的应用研究[J].国际放射医学核医学杂志,2016,40(1):1.[doi:10.3760/cma.j.issn.1673-4114.2016.01.001]
　He Yan,Su Jin,ZhengXiaoxia,et al.Developing P-glycoprotein inhibitor marked by PET[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(4):1.[doi:10.3760/cma.j.issn.1673-4114.2016.01.001]
[2]许飞,刘建军,黄钢,等.PET乏氧显像在预测肿瘤乏氧及指导临床治疗中的应用进展[J].国际放射医学核医学杂志,2016,40(1):35.[doi:10.3760/cma.j.issn.1673-4114.2016.01.008]
　Xu Fei,Liu Jianjun,Huang Gang,et al.The application of hypoxia imaging with PET in predicting tumor hypoxia and guiding clinical therapy[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(4):35.[doi:10.3760/cma.j.issn.1673-4114.2016.01.008]
[3]包明月,刘玉龙.应用间充质干细胞治疗急性辐射损伤的研究现状与进展[J].国际放射医学核医学杂志,2016,40(1):65.[doi:10.3760/cma.j.issn.1673-4114.2016.01.013]
　Bao Mingyue,Liu Yulong.Recent advances in the application of mesenchymal stem cells for treatment of acute radiation injury[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(4):65.[doi:10.3760/cma.j.issn.1673-4114.2016.01.013]
[4]陈顺军,程兵.肿瘤细胞凋亡核素显像分子探针研究进展[J].国际放射医学核医学杂志,2016,40(2):149.[doi:10.3760/cma.j.issn.1673-4114.2016.02.013]
　Chen Shunjun,Cheng Bing.Progress in molecular probes of radionuclide tumor apoptosis imaging[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(4):149.[doi:10.3760/cma.j.issn.1673-4114.2016.02.013]
[5]陈晓艳,张江虹,邵春林.STAT3与辐射敏感相关性的研究进展[J].国际放射医学核医学杂志,2016,40(3):191.[doi:10.3760/cma.j.issn.1673-4114.2016.03.007]
　Chen Xiaoyan,Jianghong,Shao Chunlin.Research progresses of correlation between STAT3 and radiosensitivity[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(4):191.[doi:10.3760/cma.j.issn.1673-4114.2016.03.007]
[6]贺欣,储小飞,罗丹,等.穿心莲药物对辐射损伤效应影响的初步研究[J].国际放射医学核医学杂志,2015,39(5):375.[doi:10. 3760 / cma. j. issn. 1673-4114. 2015. 05. 005]
　he xin,chu xiaofei,luo dan,et al.exploration of andrographolide effects on radiation injury[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(4):375.[doi:10. 3760 / cma. j. issn. 1673-4114. 2015. 05. 005]
[7]路璐,张俊伶,李德冠,等.6 gy 137cs γ射线照射对小鼠造血功能损伤的动态观察研究[J].国际放射医学核医学杂志,2015,39(5):393.[doi:10. 3760 / cma. j. issn. 1673-4114. 2015. 05. 009]
　lu lu*,zhang junling,li deguan,et al.effects of 6 gy 137cs γ-irradiattion on the hematopoietic system of mice[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(4):393.[doi:10. 3760 / cma. j. issn. 1673-4114. 2015. 05. 009]
[8]赵舒怡,储小飞,樊赛军.血清肿瘤标志物与肿瘤放疗疗效评估的研究进展[J].国际放射医学核医学杂志,2015,39(5):427.[doi:10. 3760 / cma. j. issn. 1673-4114. 2015. 05. 018]
　zhao shuyi,chu xiaofei,fan saijun..progression of study on serum tumor markers in evaluation of tumor radiotherapy[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(4):427.[doi:10. 3760 / cma. j. issn. 1673-4114. 2015. 05. 018]
[9]刘惠惠,李险峰.放射性心脏损伤诊断和防治的临床研究进展[J].国际放射医学核医学杂志,2016,40(5):374.[doi:10.3760/cma.j.issn.1673-4114.2016.05.008]
　Liu Huihui,Li Xianfeng.Clinical research progress in diagnosis,prevention and treatment of radiation-induced heart disease[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(4):374.[doi:10.3760/cma.j.issn.1673-4114.2016.05.008]
[10]赵徵鑫,翟贺争,张文艺,等.质子重离子治疗肿瘤的进展[J].国际放射医学核医学杂志,2016,40(5):384.[doi:10.3760/cma.j.issn.1673-4114.2016.05.010]
　Zhao Zhixin,Zhai Hezheng,Zhang Wenyi,et al.Development of proton heavy ion in tumor therapy[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(4):384.[doi:10.3760/cma.j.issn.1673-4114.2016.05.010]
[11]唐宇辉,陈跃.PET/CT在儿科恶性肿瘤中的应用进展[J].国际放射医学核医学杂志,2013,37(2):107.[doi:10.3760/cma.j.issn.1673-4114.2013.02.012]
　TANG Yu-hui,CHEN Yue.The progression of PET/CT in pediatric malignant tumors[J].International Journal of Radiation Medicine and Nuclear Medicine,2013,37(4):107.[doi:10.3760/cma.j.issn.1673-4114.2013.02.012]
[12]宋建波,李思进.放射性心脏损伤临床研究进展[J].国际放射医学核医学杂志,2011,35(2):117.[doi:10.3760/cma.j.issn.1673-4114.2011.02.013]
　SONG Jian-bo,LI Si-jin.Advance in clinical research of radiation-induced heart disease[J].International Journal of Radiation Medicine and Nuclear Medicine,2011,35(4):117.[doi:10.3760/cma.j.issn.1673-4114.2011.02.013]
[13]于甬华,罗立民.二次放疗的辐射耐受性研究概况[J].国际放射医学核医学杂志,2002,26(6):288.
　YU Yong-hua,LUO Li-min.Radiation-induced damage in patients of recurrence cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2002,26(4):288.
[14]孟媛媛,杨福军,徐文清.乏氧诱导因子在疾病中作用机制的研究进展[J].国际放射医学核医学杂志,2017,41(5):347.[doi:10.3760/cma.j.issn.1673-4114.2017.05.008]
　Meng Yuanyuan,Yang Fujun,Xu Wenqing.Review of retinal receptors and molecular imaging[J].International Journal of Radiation Medicine and Nuclear Medicine,2017,41(4):347.[doi:10.3760/cma.j.issn.1673-4114.2017.05.008]

备注/Memo

备注/Memo:
收稿日期:2012-05-26。
基金项目:卫生部标准研究课题(2006-09-04)
通讯作者:叶常青(Email:yechangqing01@sina.com)
更新日期/Last Update: 1900-01-01